Gabapentin (All indications)

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.15 [0.91, 1.46]0%8 studies49,613454not evaluable ROB-
Major congenital malformations1.01 [0.75, 1.35]0%8 studies49,608454not evaluable ROB-
Atrial septal defect0.79 [0.05, 12.59]-1 study3,268365not evaluable ROB-
Congenital heart defects1.73 [0.56, 5.33]32%2 studies531not evaluable ROB-
Oro-facial clefts1.49 [0.60, 3.72]0%3 studies2,816396not evaluable ROB-
Hypospadias1.55 [0.31, 7.89]0%2 studies3,378396not evaluable ROB-
Ano-rectal atresia and stenosis4.72 [0.29, 75.77]-1 study544365not evaluable ROB-
Atrioventricular septal defect4.86 [0.30, 77.92]-1 study529365not evaluable ROB-
Bilateral renal agenesis including Potter syndrome34.08 [2.11, 550.91]-1 study75365not evaluable ROB67.65 [3.64; .]
Bladder exstrophy and/or epispadia31.19 [1.93, 503.78]-1 study82365not evaluable ROB61.87 [3.27; .]
Cleft lip with or without cleft palate1.57 [0.10, 25.16]-1 study1,637365not evaluable ROB-
Cleft palate2.18 [0.14, 34.97]-1 study1,178365not evaluable ROB-
Club foot / Talipes equinovarus1.53 [0.10, 24.56]-1 study1,677365not evaluable ROB-
Coarctation of aorta3.30 [0.21, 52.90]-1 study779365not evaluable ROB-
Craniosynostosis3.36 [0.21, 53.80]-1 study766365not evaluable ROB-
Diaphragmatic hernia6.80 [0.42, 109.07]-1 study378365not evaluable ROB-
Ebstein's anomaly50.95 [3.14, 827.39]-1 study50365not evaluable ROB101.40 [5.73; .]
Gastroschisis10.57 [0.66, 169.73]-1 study243365not evaluable ROB-
Hypoplastic left heart (HLH/HLHS)11.88 [0.74, 190.96]-1 study216365not evaluable ROB-
Hypoplastic right heart (HRH/HRHS)38.69 [2.39, 626.25]-1 study66365not evaluable ROB76.88 [4.21; .]
Microcephaly / Small head circumference for gestational age5.87 [0.37, 94.12]-1 study438365not evaluable ROB-
Oesophageal atresia with or without tracheo-oesophageal fistula6.55 [0.41, 105.17]-1 study392365not evaluable ROB-
Omphalocele9.65 [0.60, 155.04]-1 study266365not evaluable ROB-
Pulmonary valve atresia16.87 [1.05, 271.48]-1 study152365not evaluable ROB33.23 [1.27; .]
Spina bifida8.40 [0.55, 128.91]-1 study617365not evaluable ROB-
Tetralogy of Fallot4.40 [0.27, 70.58]-1 study584365not evaluable ROB-
Ventricular septal defect1.11 [0.16, 7.88]-1 study4,644365not evaluable ROB-
Digestive system anomalies3.01 [0.15, 59.66]-1 study331not evaluable ROB-
Eye defects4.85 [0.09, 267.23]-1 study61not evaluable ROB-
Limb defects4.23 [0.20, 89.96]-1 study231not evaluable ROB-
Minor congenital malformations5.91 [0.11, 330.07]-1 study51not evaluable ROB-
Neural Tube Defects7.05 [0.28, 176.78]-1 study131not evaluable ROB-

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Preterm (< 37 weeks)2.38 [1.79, 3.15]0%4 studies91,697453not evaluable ROB4.19 [2.99; .]
Low birth weight (< 2500g)2.35 [1.68, 3.29]7%2 studies91,756450not evaluable ROB4.14 [2.75; .]
Small for gestational age (weight)1.23 [0.92, 1.63]0%2 studies168,024450not evaluable ROB-
Macrosomia (> 4000g)0.89 [0.72, 1.11]-1 study577,215378not evaluable ROB-
Very preterm (28 to 32 weeks)1.05 [0.26, 4.23]-1 study8,586378not evaluable ROB-
Extremely preterm (< 28 weeks)1.11 [0.07, 17.76]-1 study2,041378not evaluable ROB-

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Neonatal disorders (as a whole)1.09 [0.82, 1.46]-1 study222,254378not evaluable ROB-
Neonatal medical care2.18 [1.81, 2.62]-1 study870not evaluable ROB3.78 [3.02; .]
Withdrawal syndrome / Neonatal abstinence syndrome / Poor neonatal adaptation--0 study-

Long term consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Behavioral disorders1.10 [0.38, 3.18]-1 study14not evaluable ROB-
Child/Infant death (> 28 days of life)0.96 [0.14, 6.86]-1 study4,696378not evaluable ROB-
Emotional disorders1.13 [0.39, 3.28]-1 study14not evaluable ROB-

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Intrauterine deaths (as a whole or unspecified)4.41 [0.49, 39.98]0%3 studies317not evaluable ROB-
Early intrauterine death (< 22 weeks)4.64 [0.23, 93.20]0%2 studies23not evaluable ROB-
Elective/induced termination of pregnancy2.33 [0.03, 182.92]-1 study2not evaluable ROB-
Therapeutic terminations of pregnancy2.33 [0.03, 182.92]-1 study2not evaluable ROB-
Late intrauterine deaths (> 22 weeks)47.00 [0.38, 5814.69]-1 study1not evaluable ROB-

Neuro-developmental disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
ASD (Autism spectrum disorder): Diagnosis1.34 [0.40, 4.45]58%3 studies4,5581,344not evaluable ROB-
ASD (Autism spectrum disorder): Diagnosis/Risk1.34 [0.40, 4.45]58%3 studies4,5581,344not evaluable ROB-
Neuro-developmental disorders (as a whole)0.96 [0.44, 2.10]32%4 studies10,4751,345not evaluable ROB-
Language disorders/delay0.62 [0.36, 1.05]0%2 studies72,028392not evaluable ROB-
Cognitive developmental disorders/delay (3-6 years old)0.67 [0.04, 10.66]-1 study3,398378not evaluable ROB-
Severe cognitive developmental delay (Mental retardation) (3-6 years old)0.67 [0.04, 10.66]-1 study3,398378not evaluable ROB-
ADHD (Attention deficit hyperactivity disorder): Diagnosis/Risk0.87 [0.30, 2.52]-1 study14not evaluable ROB-
ADHD (Attention deficit hyperactivity disorder): Risk0.87 [0.30, 2.52]-1 study14not evaluable ROB-
ASD (Autism spectrum disorder): Risk17.00 [0.13, 2166.90]-1 study1not evaluable ROB-
Cognitive developmental disorders/delay (> 6 years old)1.33 [0.13, 13.89]-1 study414not evaluable ROB-

Hide endpoints reported in only one study ...

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons